Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 92 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 1821

Topic: Biology, Genetics & Bone Healing

A 65-year-old male presents with generalized bone pain, fatigue, and a recent pathologic fracture of the proximal humerus. Laboratory testing reveals hypercalcemia, anemia, and renal insufficiency. A skeletal survey demonstrates multiple punched-out lytic lesions in the skull and pelvis. The neoplastic cells primarily responsible for this condition are derived from which of the following cell lineages?

. T-lymphocytes
. B-lymphocytes (Plasma cells)
. Osteoclasts
. Mesenchymal stem cells
. Hematopoietic stem cells of the myeloid lineage

Correct Answer & Explanation

. B-lymphocytes (Plasma cells)

Explanation

The patient's clinical presentation is classic for multiple myeloma, fulfilling the CRAB criteria (hyperCalcemia, Renal insufficiency, Anemia, Bone lesions). Multiple myeloma is a plasma cell dyscrasia characterized by the neoplastic proliferation of monoclonal plasma cells, which are terminally differentiated B-lymphocytes. These malignant cells secrete monoclonal immunoglobulins and stimulate aggressive osteoclastic bone resorption via upregulation of RANKL and downregulation of osteoprotegerin (OPG).

Question 1822

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with persistent knee pain. Radiographs reveal an eccentric, purely lytic, epiphyseal-metaphyseal lesion in the distal femur extending to the subchondral bone without a sclerotic margin. Biopsy confirms a giant cell tumor of bone. She is scheduled for curettage but is prescribed a targeted biologic therapy preoperatively to downstage the tumor. What is the precise mechanism of action of this medication?

. Inhibition of vascular endothelial growth factor (VEGF)
. Direct binding to the RANK receptor on the surface of multinucleated giant cells
. Monoclonal antibody binding to RANK ligand (RANKL)
. Inhibition of tyrosine kinase receptors on mononuclear stromal cells
. Direct binding to osteoclast integrin receptors

Correct Answer & Explanation

. Monoclonal antibody binding to RANK ligand (RANKL)

Explanation

The patient is describing Denosumab, which is used in the treatment of Giant Cell Tumor (GCT) of bone. The neoplastic cells in GCT are the mononuclear spindle-shaped stromal cells, which express high levels of RANK Ligand (RANKL). This RANKL recruits and activates reactive, non-neoplastic multinucleated giant cells (osteoclast-like cells) that cause the massive bone destruction seen in this disease. Denosumab is a fully humanized monoclonal antibody that binds directly to RANKL, preventing it from interacting with the RANK receptor on the osteoclast-like giant cells. It does not bind to the RANK receptor itself.

Question 1823

Topic: Biology, Genetics & Bone Healing

In the process of creeping substitution during the incorporation of a massive structural cortical bone allograft, what is the primary mechanism of graft failure in the first few years?

. An excessive immune response leading to acute rejection
. Complete resorption of the graft by osteoclasts before osteoblastic bone formation
. Fatigue microdamage leading to fracture due to incomplete revascularization and remodeling
. Transformation into a malignant sarcoma due to chronic inflammation
. Failure of woven bone to convert to lamellar bone

Correct Answer & Explanation

. Fatigue microdamage leading to fracture due to incomplete revascularization and remodeling

Explanation

Structural cortical allografts undergo creeping substitution, which starts at the graft-host junction and slowly progresses. Because only the outer few millimeters typically become revascularized and remodeled, the bulk of the graft remains necrotic and acts primarily as a mechanical spacer. The remodeling process transiently weakens the graft because osteoclastic resorption precedes osteoblastic formation. This leaves the graft highly susceptible to fatigue microdamage, which can accumulate and result in structural failure (fracture) during the first few years.

Question 1824

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with a painful, radiolucent, eccentrically located lesion in the distal femoral epiphysis extending to the subchondral bone. Biopsy reveals multinucleated giant cells interspersed within a stroma of mononuclear cells. Which of the following best describes the mechanism of action of the targeted medical therapy typically used for advanced or unresectable cases of this condition?

. Inhibition of matrix metalloproteinases
. Monoclonal antibody targeting RANK ligand (RANKL)
. Tyrosine kinase inhibition of c-KIT
. Alkylating agent causing DNA cross-linking
. Competitive inhibition of estrogen receptors

Correct Answer & Explanation

. Monoclonal antibody targeting RANK ligand (RANKL)

Explanation

The clinical and histologic presentation is classic for a giant cell tumor of bone (GCT). The mononuclear stromal cells are the true neoplastic cells, and they overexpress RANK ligand (RANKL). This recruits and activates normal multinucleated osteoclast-like giant cells, causing extensive bone resorption. Denosumab, a monoclonal antibody that binds to RANKL, prevents the RANK-RANKL interaction, effectively inhibiting osteoclast formation and reducing osteolysis.

Question 1825

Topic: Biology, Genetics & Bone Healing

Nitrogen-containing bisphosphonates, such as alendronate and zoledronic acid, inhibit osteoclast-mediated bone resorption primarily by interfering with which of the following intracellular pathways?

. Wnt/beta-catenin signaling
. Mevalonate pathway via inhibition of farnesyl pyrophosphate synthase
. NF-kB pathway via inhibition of RANKL
. Glycolytic pathway via inhibition of hexokinase
. Arachidonic acid cascade via COX-2 inhibition

Correct Answer & Explanation

. Mevalonate pathway via inhibition of farnesyl pyrophosphate synthase

Explanation

Nitrogen-containing bisphosphonates (e.g., alendronate, risedronate, zoledronate) act by inhibiting the enzyme farnesyl pyrophosphate synthase within the mevalonate pathway. This prevents the prenylation of small GTPase proteins (such as Ras, Rho, and Rab), which are essential for normal osteoclast function, ruffled border formation, and cell survival, ultimately leading to osteoclast apoptosis. Non-nitrogen-containing bisphosphonates (e.g., etidronate) act differently, by forming toxic ATP analogues.

Question 1826

Topic: Biology, Genetics & Bone Healing

During the initial inflammatory phase of fracture healing, which of the following cytokines is considered the primary early initiator of the cascade, promoting angiogenesis and the recruitment of mesenchymal stem cells, and peaks within the first 24 hours?

. Bone Morphogenetic Protein-2 (BMP-2)
. Transforming Growth Factor-beta (TGF-beta)
. Tumor Necrosis Factor-alpha (TNF-alpha)
. Interleukin-10 (IL-10)
. Fibroblast Growth Factor-2 (FGF-2)

Correct Answer & Explanation

. Tumor Necrosis Factor-alpha (TNF-alpha)

Explanation

Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1 (IL-1) are key pro-inflammatory cytokines that peak within the first 24 hours after a fracture. They are secreted by macrophages and inflammatory cells in the fracture hematoma. TNF-alpha is essential for initiating the repair cascade, recruiting mesenchymal stem cells, and promoting angiogenesis. The absence of TNF-alpha signaling has been shown to significantly delay fracture healing. BMP-2 and TGF-beta are critical later in the process for driving chondrogenesis and osteogenesis.

Question 1827

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with knee pain. Radiographs demonstrate an eccentric, lytic epiphyseal lesion in the distal femur extending to the subchondral bone. Biopsy confirms a giant cell tumor of bone. In cases of unresectable disease, medical therapy can be utilized to downstage the tumor. Which of the following describes the mechanism of action of the most commonly used targeted medication for this condition?

. Inhibition of vascular endothelial growth factor (VEGF)
. Direct apoptosis of the neoplastic mononuclear cells
. Monoclonal antibody binding to RANK ligand (RANKL)
. Bisphosphonate-mediated inhibition of osteoclast farnesyl pyrophosphate synthase
. Tyrosine kinase inhibition of c-KIT

Correct Answer & Explanation

. Monoclonal antibody binding to RANK ligand (RANKL)

Explanation

Denosumab is the targeted medical therapy for advanced or unresectable giant cell tumors of bone (GCT). It is a monoclonal antibody that binds to RANKL. In GCT, the neoplastic cells are the mononuclear stromal cells, which express high levels of RANKL. This RANKL normally recruits and activates the reactive, multinucleated osteoclast-like giant cells that cause bone destruction. Denosumab disrupts this pathway, halting bone resorption and tumor progression.

Question 1828

Topic: Biology, Genetics & Bone Healing

A 68-year-old woman presents with generalized back pain and fatigue. Radiographs show multiple punched-out lytic lesions in her skull and spine. Laboratory studies reveal hypercalcemia and elevated serum creatinine. A technetium-99m bone scan is ordered but shows no areas of increased radiotracer uptake in the skeleton. What is the most likely explanation for the false-negative bone scan?

. The lesions are primarily composed of calcified cartilage
. The lesions represent areas of pure osteoblastic activity
. The patient has concurrent severe osteoporosis limiting radiotracer uptake
. Technetium-99m primarily binds to tumor-specific antigens not present in this disease
. The tumor cells produce osteoclast activating factors without a significant osteoblastic response

Correct Answer & Explanation

. The tumor cells produce osteoclast activating factors without a significant osteoblastic response

Explanation

This patient has multiple myeloma, characterized by 'punched-out' lytic lesions, hypercalcemia, and renal failure. Technetium-99m bone scans detect areas of active osteoblastic bone formation (woven bone). Multiple myeloma cells secrete factors that potently activate osteoclasts (e.g., RANKL) while simultaneously suppressing osteoblast activity (e.g., DKK1). Because there is little to no reactive bone formation, the lesions are purely osteolytic and often do not 'light up' on a standard bone scan.

Question 1829

Topic: Biology, Genetics & Bone Healing

A 70-year-old man presents with increasing hat size, progressive hearing loss, and thigh pain. Radiographs of his femur show cortical thickening and coarse trabeculae. Laboratory tests show normal serum calcium, normal phosphate, and markedly elevated serum alkaline phosphatase. Which of the following describes the primary pathological event initiating this disease process?

. Decreased osteoblast proliferation
. Malignant transformation of osteoblasts
. Intense, uncoupled osteoclastic bone resorption
. Vitamin D deficiency leading to unmineralized osteoid
. Deposition of beta-2 microglobulin amyloid in bone

Correct Answer & Explanation

. Intense, uncoupled osteoclastic bone resorption

Explanation

Paget's disease of bone (osteitis deformans) is initiated by an intense, overactive osteoclastic resorptive phase. These osteoclasts are abnormally large and have an increased number of nuclei. This initial lytic phase is followed by a mixed phase where chaotic osteoblastic bone formation attempts to compensate, leading to the deposition of structurally weak woven bone. This ultimately results in the sclerotic phase characterized by thickened cortices and a 'mosaic' cement line pattern on histology.

Question 1830

Topic: Biology, Genetics & Bone Healing

Recombinant human bone morphogenetic protein-2 (rhBMP-2) signals through serine/threonine kinase receptors. Which of the following intracellular signaling molecules is directly phosphorylated following the binding of rhBMP-2 to its receptor?

. Wnt
. Beta-catenin
. Smad 1/5/8
. Smad 2/3
. Runx2

Correct Answer & Explanation

. Smad 1/5/8

Explanation

BMPs signal primarily through the Smad pathway. BMPs (such as BMP-2 and BMP-7) bind to transmembrane serine/threonine kinase receptors, which then phosphorylate Smad 1, 5, and 8. These phosphorylated molecules complex with Smad 4 and enter the nucleus to upregulate transcription factors such as Runx2. TGF-beta, on the other hand, primarily phosphorylates Smad 2 and 3. The Wnt pathway signals via beta-catenin stabilization.

Question 1831

Topic: Biology, Genetics & Bone Healing

During secondary fracture healing, the cartilaginous soft callus is replaced by a hard bony callus. This specific phase of tissue differentiation and replacement is driven primarily by which of the following mechanisms?

. Intramembranous ossification
. Endochondral ossification
. Creeping substitution
. Appositional growth
. Osteoclastic cutting cones

Correct Answer & Explanation

. Endochondral ossification

Explanation

Secondary fracture healing progresses through inflammation, soft callus formation, hard callus formation, and remodeling. The transition from a cartilaginous soft callus to a woven bone hard callus occurs via endochondral ossification. Intramembranous ossification occurs directly from mesenchymal cells without a cartilaginous intermediate, which is seen in flat bone development and the immediate periosteal response at the fracture edges.

Question 1832

Topic: Biology, Genetics & Bone Healing

Which of the following bone morphogenetic proteins (BMPs) has been approved by the FDA as an alternative to autogenous bone graft for acute, open tibial shaft fractures treated with an intramedullary nail?

. BMP-2
. BMP-3
. BMP-4
. BMP-7
. BMP-9

Correct Answer & Explanation

. BMP-2

Explanation

Recombinant human BMP-2 (rhBMP-2) is FDA-approved for acute, open tibial shaft fractures stabilized with an intramedullary nail, as well as for certain anterior lumbar interbody fusions. It induces bone formation via the SMAD signaling pathway. BMP-7 (OP-1) previously held a humanitarian device exemption for recalcitrant tibial nonunions but is not approved for acute open tibial fractures.

Question 1833

Topic: Biology, Genetics & Bone Healing

Sclerostin is a critical regulatory glycoprotein in bone metabolism and is therapeutically targeted by the monoclonal antibody romosozumab. What is the precise cellular mechanism of action by which sclerostin inhibition leads to an increase in bone mass?

. Binding to RANKL to prevent osteoclast activation
. Direct inhibition of the Wnt/beta-catenin signaling pathway in osteoblasts
. Activation of Wnt/beta-catenin signaling by preventing Sclerostin from binding to LRP5/6 receptors
. Direct stimulation of alkaline phosphatase production in the osteocytes
. Upregulation of osteoprotegerin (OPG) production

Correct Answer & Explanation

. Activation of Wnt/beta-catenin signaling by preventing Sclerostin from binding to LRP5/6 receptors

Explanation

Sclerostin (produced by osteocytes) normally inhibits the Wnt/beta-catenin pathway by binding to the LRP5/6 co-receptors on osteoblasts, leading to decreased bone formation. Inhibiting sclerostin prevents this binding, allowing Wnt signaling to proceed unhindered, which drastically increases osteoblast activity and bone formation.

Question 1834

Topic: Biology, Genetics & Bone Healing

Articular cartilage is a highly specialized connective tissue designed to withstand repetitive compressive forces. In the deep (basal) zone of articular cartilage, the arrangement of type II collagen fibers and the morphology of chondrocytes are best described by which of the following statements?

. Collagen fibers are parallel to the joint surface; chondrocytes are flattened.
. Collagen fibers are parallel to the joint surface; chondrocytes are spherical.
. Collagen fibers are perpendicular to the joint surface; chondrocytes are arranged in a columnar orientation.
. Collagen fibers are randomly oriented; chondrocytes are sparse and irregular.
. Collagen fibers are oblique to the joint surface; chondrocytes are hypertrophic.

Correct Answer & Explanation

. Collagen fibers are perpendicular to the joint surface; chondrocytes are arranged in a columnar orientation.

Explanation

In the deep (basal) zone of articular cartilage, collagen type II fibers are arranged perpendicular (vertical) to the joint surface to provide resistance to high compressive loads. The chondrocytes in this zone are typically spherical and arranged in columns parallel to these collagen fibers. The superficial zone, by contrast, contains flattened chondrocytes with fibers running parallel to the articular surface to resist shear forces.

Question 1835

Topic: Biology, Genetics & Bone Healing




During secondary fracture healing in a long bone treated with a cast, the progression from a soft cartilaginous callus to a hard bony callus occurs primarily via which of the following physiological processes?

. Intramembranous ossification
. Endochondral ossification
. Appositional bone growth
. Haversian remodeling
. Creeping substitution

Correct Answer & Explanation

. Endochondral ossification

Explanation

Secondary fracture healing occurs under conditions of relative stability (e.g., casting, intramedullary nailing) and involves callus formation. The critical transition from a soft (cartilage) callus to a hard (woven bone) callus takes place primarily through endochondral ossification. While intramembranous ossification (bone forming directly from mesenchymal cells without a cartilage model) can occur subperiosteally at the periphery of the fracture site, the central bridging of the gap relies on endochondral ossification.

Question 1836

Topic: Biology, Genetics & Bone Healing

A 28-year-old male sustains a closed tibia fracture and undergoes intramedullary nailing. He has delayed union and receives recombinant human bone morphogenetic protein-2 (rhBMP-2). BMPs stimulate bone formation primarily by acting through which of the following intracellular signaling pathways?

. Binding to intracellular steroid receptors to stimulate transcription
. Binding to serine/threonine kinase receptors and signaling via Smad proteins
. Activating tyrosine kinase receptors and the MAPK pathway
. Inhibiting osteoclastogenesis via the RANK/RANKL pathway
. Acting as a structural scaffold for osteoblast attachment

Correct Answer & Explanation

. Binding to serine/threonine kinase receptors and signaling via Smad proteins

Explanation

Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily. They bind to cell-surface transmembrane serine/threonine kinase receptors. Upon binding, the receptor complex phosphorylates intracellular Smad proteins (Smad 1, 5, 8), which then complex with Smad 4, translocate to the nucleus, and regulate the transcription of target genes necessary for osteoblastic differentiation.

Question 1837

Topic: Biology, Genetics & Bone Healing

A 45-year-old woman presents with knee pain. Radiographs reveal an eccentric, lytic lesion in the distal femoral epiphysis extending to the articular surface. Biopsy demonstrates mononuclear cells intermixed with multinucleated giant cells. Which of the following best describes the molecular mechanism of the targeted medical therapy for this condition?

. Inhibition of tyrosine kinase signaling
. Monoclonal antibody binding to RANKL, preventing RANK activation
. Monoclonal antibody binding directly to RANK, blocking RANKL binding
. Bisphosphonate-mediated inhibition of farnesyl pyrophosphate synthase
. Inhibition of the hedgehog signaling pathway

Correct Answer & Explanation

. Monoclonal antibody binding to RANKL, preventing RANK activation

Explanation

The clinical presentation and histology describe a giant cell tumor (GCT) of bone. The neoplastic mononuclear cells in GCT express RANKL, which recruits and activates the reactive multinucleated osteoclast-like giant cells that cause bone resorption. Denosumab, a human monoclonal antibody, specifically targets and binds to RANKL, thereby preventing the activation of the RANK receptor on osteoclasts and osteoclast precursors. This leads to reduced bone resorption and tumor stabilization.

Question 1838

Topic: Biology, Genetics & Bone Healing
Which of the following cellular components is essential for the sealing zone formation and subsequent osteoclast attachment to the bone matrix during bone resorption?
. Integrin alpha-v beta-3
. Cadherin-11
. Connexin 43
. CD44
. Fibronectin

Correct Answer & Explanation

. Integrin alpha-v beta-3

Explanation

Osteoclasts attach to the bone matrix to create an isolated extracellular microenvironment for resorption. This attachment is mediated primarily by integrin alpha-v beta-3 (αvβ3), which binds to bone matrix proteins containing an RGD (Arg-Gly-Asp) sequence, such as osteopontin and bone sialoprotein. This interaction forms the 'sealing zone' and leads to the polarization of the osteoclast and formation of the ruffled border.

Question 1839

Topic: Biology, Genetics & Bone Healing
During the process of secondary fracture healing, which type of collagen is predominantly synthesized first by chondrocytes during the soft callus phase?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen

Explanation

Secondary fracture healing proceeds through hematoma, soft callus, hard callus, and remodeling phases. The soft callus is primarily cartilaginous and is rich in Type II collagen, which is produced by proliferating chondrocytes. Type X collagen appears later during chondrocyte hypertrophy, and Type I collagen replaces the cartilage matrix during the hard callus and remodeling phases.

Question 1840

Topic: Biology, Genetics & Bone Healing

Osteoclastogenesis and the resorptive activity of osteoclasts are heavily regulated by the osteoblast lineage. Which of the following systemic hormones exerts its catabolic bone effect by directly binding to osteoblasts, subsequently upregulating RANKL expression and downregulating osteoprotegerin (OPG)?

. Calcitonin
. Parathyroid hormone (PTH)
. 1,25-dihydroxyvitamin D3
. Estrogen
. Transforming growth factor-beta (TGF-beta)

Correct Answer & Explanation

. Parathyroid hormone (PTH)

Explanation

Parathyroid hormone (PTH) regulates serum calcium by stimulating bone resorption. Because osteoclasts lack PTH receptors, PTH binds to PTH1R receptors on osteoblasts. This stimulates the osteoblasts to increase their expression of RANKL and decrease the secretion of OPG. The elevated RANKL/OPG ratio promotes osteoclast differentiation, maturation, and survival, leading to increased bone resorption.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page